Citations

Clear

400 citation(s) found for "Sm, Berry".

The Effects of Mild Traumatic Brain Injury, Post-Traumatic Stress Disorder, and Combined Mild Traumatic Brain Injury/Post-Traumatic Stress Disorder on Returning Veterans
Combs, Hannah L. , Berry, David T. R., Pape, Theresa , Babcock‐Parziale, Judith, Schleenbaker, Randal E., Shandera‐Ochsner, Anne L., Harp, Jordan P. , High, Walter M., Shandera-Ochsner, Anne, Smith, Bridget

Mayo Clinic

Journal of Neurotrauma | October 28, 2014 | Volume: 32 | Issue: 13 | Pages: 956-966

10.1089/neu.2014.3585 | PMID 25350012 Get It

Dysarthria in Wilson’s Disease
Berry, William R. , Darley, Frederic L., Goldstein, Norman, Aronson, Arnold

Mayo Clinic

Journal of Speech and Hearing Research | July 29, 2014 | Volume: 17 | Issue: 2 | Pages: 169-183

10.1044/jshr.1702.169 | PMID 4836038 Get It

Three judges rated a number of speech characteristics of 20 patients with Wilson’s disease, an inherited metabolic disease. The perceptual data suggest the presence of a mixed dysarthria with prominent ataxic, spastic, and hypokinetic features which were predictable from neurologic data on the patients. Perceptual data on 10 patients, recorded at two specific points in a treatment program, indicate that speech can be used as an effective monitor of progress in the treatment of this disease.
African American Women's Perceptions and Attitudes Regarding Participation in Medical Research: The Mayo Clinic/The Links, Incorporated Partnership
Brewer, LaPrincess C. , Hayes, Sharonne N. , Parker, Monica W. , Balls‐Berry, Joyce E. , Halyard, Michele Y. , Pinn, Vivian W. , Breitkopf, Carmen Radecki , Balls-Berry, Joyce Joy E , Hayes, Sharonne N , Brewer, LaPrincess C

Mayo Clinic

Journal of Women's Health | July 21, 2014 | Volume: 23 | Issue: 8 | Pages: 681-687

10.1089/jwh.2014.4751 | PMID 25046058 Get It

Objective: To examine perceptions and attitudes toward health-related research participation among professional African American women. Methods: Participants were members of an African American women's service organization, The Links, Incorporated. Data were collected via self-administered questionnaires at The Links, Incorporated 2012 National Assembly. Sociodemographics, prior research experience, intention to participate (ITP), willingness to participate (WTP) in a variety of research studies and attitudes about research participation were measured. Results: A total of 381 surveys were analyzed. A majority of respondents were married (66%), employed (69%), and college educated (96%). Median age was 59; 38% reported prior research participation. Overall, 78% agreed with the statement, “Participation in research will mean better care,” 24% agreed “Participation in research is risky” and 3% agreed “Scientists cannot be trusted.” Fifty-two percent agreed with the statement, “Research conducted in the U.S. is ethical.” Mean ITP in research was 4.9±1.7 on a rating scale of 1 (“definitely no”) to 7 (“definitely yes”). WTP was highest for an interview study and providing a blood sample, and lowest for clinical trial and medical record review. Conclusion: Attitudes toward research participation were generally favorable among professional African American women; many expressed WTP in a variety of research study types.
Comparison of Doxorubicin and Cyclophosphamide Versus Single-Agent Paclitaxel As Adjuvant Therapy for Breast Cancer in Women With 0 to 3 Positive Axillary Nodes: CALGB 40101 (Alliance)
Berry, Donald A. , Cirrincione, Constance, Becker, Heather P., Perez, Edith A. , Martino, Silvana, Kimmick, Gretchen , Burstein, Harold J. , Norton, Larry , Muss, Hyman B. , Hudis, Clifford A. , Shulman, Lawrence N. , Cirrincione, Constance T, O'Regan, Ruth, Shapiro, Charles L. , Schneider, Charles J, Muss, Hyman, O'Regan, Ruth M , Schneider, Charles John , Winer, Eric P. , Norton, Larry

Mayo Clinic

Journal of Clinical Oncology | June 17, 2014 | Volume: 32 | Issue: 22 | Pages: 2311-2317

10.1200/jco.2013.53.7142 | PMID 24934787 Get It

PurposeOptimal adjuvant chemotherapy for early-stage breast cancer balances efficacy and toxicity. We sought to determine whether single-agent paclitaxel (T) was inferior to doxorubicin and cyclophosphamide (AC), when each was administered for four or six cycles of therapy, and whether it offered less toxicity.Patients and MethodsPatients with operable breast cancer with 0 to 3 positive nodes were enrolled onto the study to address the noninferiority of single-agent T to AC, defined as the one-sided 95% upper-bound CI (UCB) of hazard ratio (HR) of T versus AC less than 1.30 for the primary end point of relapse-free survival (RFS). As a 2 × 2 factorial design, duration of therapy was also addressed and was previously reported.ResultsWith 3,871 patients enrolled onto the trial, a median follow-up period of 6.1 years, and 437 RFS events, we achieved an HR of 1.26 (one sided 95% UCB, 1.48; favoring AC does not allow a conclusion of noninferiority of T with AC; UCB > 1.3). With 266 patient deaths, the HR for overall survival (OS) was 1.27 favoring AC (UCB, 1.56). The estimated absolute advantage of AC at 5 years is 3% for RFS (91 v 88%) and 1% for OS (95 v 94%). All nine treatment-related deaths were patients receiving AC and are included in the analyses of both RFS and OS. Hematologic toxicity was more common in patients treated with AC, and neuropathy was more common in patients treated with T.ConclusionThis trial did not show noninferiority of T to AC, a conclusion that is unlikely to change with additional events and follow-up. T was less toxic than AC.
Human Bone Marrow: A Reservoir for “Enhanced Effector Memory” CD8+ T Cells with Potent Recall Function
Zhang, Xiaoyu , Lin, Wei, Voss, Stephen G. , Hinkley, Lucinda, Westergren, Melissa, Tian, Guo‐Liang , Berry, Daniel J. , Lewellen, D. C., Vile, Richard G. , Strome, Scott E. , Dong, Haidong , Chen, Lieping , Färber, Donna L. , Berry, Daniel J

Mayo Clinic

The Journal of Immunology | April 18, 2014 | Volume: 177 | Issue: 10 | Pages: 6730-6737

10.4049/jimmunol.177.10.6730 | PMID 17082586 Get It

Abstract The role of human bone marrow (BM) CD8+ T cells in the immune response to viral Ags is poorly defined. We report here the identification and characterization of a functionally enhanced effector memory CD8+ T cell population (TEM) in the BM of patients undergoing total joint replacement for osteoarthritis. These BM-derived TEM differ strikingly from correlate cells in peripheral blood (PB), expressing elevated levels of CD27, HLA-DR, CD38, CD69, and unique patterns of chemokine receptors. Interestingly, while BM TEM have low levels of resting perforin and granzyme B, these molecules evidence profound up-regulation in response to TCR stimulation resulting in enhanced cytotoxic potential. Moreover, compared with the TEM subset in PB, BM CD8+ TEM cells demonstrate a more vigorous recall response to pooled viral Ags. Our results reveal that human BM serves as a repository for viral Ag-specific TEM with great therapeutic potential in vaccine development.
Improving Service Quality in Primary Care
Kennedy, Denise M. , Nordrum, Jon T., Edwards, Frederick , Caselli, Richard J., Edwards, Frederick D, Caselli, Richard J. , Berry, Leonard L.

Mayo Clinic

American Journal of Medical Quality | January 14, 2014 | Volume: 30 | Issue: 1 | Pages: 45-51

10.1177/1062860613518093 | PMID 24418754 Get It

Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma
Han, Dale , Shyr, Yu , Chen, Heidi , Berry, Lynne D. , Iyengar, Sanjana, Djulbegovic, Mia , Weber, J, Marzban, Suroosh S., Sondak, Vernon K. , Messina, Jane L. , Vetto, John T. , White, Richard L. , Pockaj, Barbara A. , Mozzillo, Nicola, Charney, Kim, Avisar, Eli , Kashani–Sabet, Mohammed , Leong, Stanley P. L. , Zager, Jonathan S. , Krouse, Robert S.

Mayo Clinic

Journal of Clinical Oncology | November 4, 2013 | Volume: 31 | Issue: 35 | Pages: 4387-4393

10.1200/jco.2013.50.1114 | PMID 24190111 Get It

Purpose Indications for sentinel lymph node biopsy (SLNB) for thin melanoma are continually evolving. We present a large multi-institutional study to determine factors predictive of sentinel lymph node (SLN) metastasis in thin melanoma. Patients and Methods Retrospective review of the Sentinel Lymph Node Working Group database from 1994 to 2012 identified 1,250 patients who had an SLNB and thin melanomas (≤ 1 mm). Clinicopathologic characteristics were correlated with SLN status and outcome. Results SLN metastases were detected in 65 (5.2%) of 1,250 patients. On univariable analysis, rates of Breslow thickness ≥ 0.75 mm, Clark level ≥ IV, ulceration, and absence of regression differed significantly between positive and negative SLN groups (all P < .05). These four variables and mitotic rate were used in multivariable analysis, which demonstrated that Breslow thickness ≥ 0.75 mm (P = .03), Clark level ≥ IV (P = .05), and ulceration (P = .01) significantly predicted SLN metastasis with 6.3%, 7.0%, and 11.6% of the patients with these respective characteristics having SLN disease. Melanomas < 0.75 mm had positive SLN rates of < 5% regardless of Clark level and ulceration status. Median follow-up was 2.6 years. Melanoma-specific survival was significantly worse for patients with positive versus negative SLNs (P = .001). Conclusion Breslow thickness ≥ 0.75 mm, Clark level ≥ IV, and ulceration significantly predict SLN disease in thin melanoma. Most SLN metastases (86.2%) occur in melanomas ≥ 0.75 mm, with 6.3% of these patients having SLN disease, whereas in melanomas < 0.75 mm, SLN metastasis rates are < 5%. By using a 5% metastasis risk threshold, SLNB is indicated for melanomas ≥ 0.75 mm, but further study is needed to define indications for SLNB in melanomas < 0.75 mm.
Acetabular fractures
Mabry, Tad M. , Sems, S.A. , Berry, Daniel J. , Sierra, Rafael J. , Berry, Daniel J

Mayo Clinic

The Bone & Joint Journal | November 1, 2013 | Volume: 95-B | Issue: 11_Supple_A | Pages: 11-16

10.1302/0301-620x.95b11.32897 | PMID 24187344 Get It

Total hip replacement (THR) after acetabular fracture presents unique challenges to the orthopaedic surgeon. The majority of patients can be treated with a standard THR, resulting in a very reasonable outcome. Technical challenges however include infection, residual pelvic deformity, acetabular bone loss with ununited fractures, osteonecrosis of bone fragments, retained metalwork, heterotopic ossification, dealing with the sciatic nerve, and the difficulties of obtaining long-term acetabular component fixation. Indications for an acute THR include young patients with both femoral head and acetabular involvement with severe comminution that cannot be reconstructed, and the elderly, with severe bony comminution. The outcomes of THR for established post-traumatic arthritis include excellent pain relief and functional improvements. The use of modern implants and alternative bearing surfaces should improve outcomes further. Cite this article: Bone Joint J 2013;95-B, Supple A:11–16.
Post-lumbar puncture headache is reduced with use of atraumatic needles in ALS
Macklin, Eric A. , Atassi, Nazem , Bowser, Robert , Cudkowicz, Merit , Fournier, Christina , Ladha, Shafeeq , Lacomis, David , Quinn, Colin , Boylan, Khrista , Berry, James D. , Ladha, Shafeeq , Cudkowicz, Merit E

Mayo Clinic

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | July 8, 2013 | Volume: 14 | Issue: 7-8 | Pages: 632-634

10.3109/21678421.2013.808227 | PMID 23834161 Get It

Innovations in Access to Care: A Patient-Centered Approach
Seiders, Kathleen, Wilder, Susan S., Berry, Leonard L.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 139 | Issue: 7 | Pages: 568-574

10.7326/0003-4819-139-7-200310070-00009 | PMID 14530228 Get It